BioRestorative Therapies, Inc.
BRTX
$1.57
-$0.04-2.48%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.38M | 9.11M | 10.73M | 13.09M | 14.68M |
Total Receivables | 15.00K | 25.00K | 188.40K | 165.00K | 27.40K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 184.60K | 217.40K | 223.20K | 233.70K | 295.90K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 17.30K | -- | -- | 22.40K | -- |
Total Current Assets | 7.60M | 9.36M | 11.14M | 13.51M | 15.00M |
|
|||||
Total Current Assets | 7.60M | 9.36M | 11.14M | 13.51M | 15.00M |
Net Property, Plant & Equipment | 339.70K | 370.00K | 362.90K | 418.10K | 424.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 579.10K | 601.50K | 623.90K | 646.40K | 668.80K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 148.70K | -- | 22.40K |
Total Assets | 8.52M | 10.33M | 12.28M | 14.57M | 16.12M |
|
|||||
Total Accounts Payable | 609.90K | 599.50K | 483.10K | 401.40K | 215.90K |
Total Accrued Expenses | 480.90K | 277.60K | 744.50K | 682.20K | 447.60K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | 42.40K | 83.60K |
Total Finance Division Other Current Liabilities | 2.58M | 3.31M | 2.52M | 3.46M | 4.57M |
Total Other Current Liabilities | 2.58M | 3.31M | 2.52M | 3.46M | 4.57M |
Total Current Liabilities | 3.67M | 4.18M | 3.75M | 4.58M | 5.32M |
|
|||||
Total Current Liabilities | 3.67M | 4.18M | 3.75M | 4.58M | 5.32M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.67M | 4.18M | 3.75M | 4.58M | 5.32M |
|
|||||
Common Stock & APIC | 168.51M | 167.15M | 164.20M | 164.02M | 163.74M |
Retained Earnings | -163.67M | -161.02M | -155.68M | -154.04M | -152.95M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4.83M | 6.13M | 8.52M | 9.98M | 10.79M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
|
|||||
Total Common Equity | 4.83M | 6.13M | 8.52M | 9.98M | 10.79M |
Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.85M | 6.14M | 8.53M | 9.99M | 10.80M |
|